Deciding What Drugs Will Be Covered

CLOSED: This discussion has concluded.

Pharmacare is a system of health insurance that provides people with access to necessary prescription drugs. The scope of drugs eligible for coverage through a pharmacare plan can vary.

One approach would be to limit coverage to those prescription drugs for which there is good evidence of both effectiveness and value-for-money. This approach would result in a less costly plan, but provide fewer options for some patients. 

Another approach would be to expand the list of covered drugs to include those for which there is less evidence of value-for-money, e.g., to include higher-cost drugs that may have little clinical evidence supporting how well they work. This approach would result in a more costly plan, but provide more options for some patients.

How extensive a selection of drugs should be covered under a national pharmacare program? Share your thoughts below:

Thank you for your interest in this consultation with the Advisory Council on the Implementation of National Pharmacare. 

The online consultation is now closed, and written submissions are no longer being accepted. 

In March 2019, the Council provided an interim report to the Minister of Health and the Minister of Finance on the progress of their work.

The Council released its final report in June 2019.

For more information on the Council, please visit the following link:

Keep in touch with us via email at


Advisory Council on the Implementation of National Pharmacare

    <span class="translation_missing" title="translation missing:">Load Comment Text</span>